WASHINGTON, DC – As organizations committed to protecting the health of our nation’s children, we strongly urge the Trump Administration to side with America’s kids over the tobacco industry by implementing its plan to clear the market of all flavored e-cigarettes – including mint and menthol fla
Washington, D.C. – Today the House Energy and Commerce Subcommittee on Health is holding a hearing on legislation that would prohibit the sale of nearly all flavored tobacco products, including mint and menthol products, and raise the minimum age of sale of tobacco products to 21.
House Speaker, Nancy Pelosi (D-Calif.), introduced legislation intended to bring down patient drug costs.
The Senate Labor, Health and Human Services and Education Subcommittee (LHHS) posted a draft FY 2020 spending bill today that includes a $3 billion funding increase for the National Institutes of Health (NIH), a $5 million increase for cancer registries and a $1 million increase for skin cancer programs, both of which operate at the Centers for Disease Control and Prevention.
the Trump administration announced its intention to finalize compliance policy through the Department of Health and Human Services (HHS) and Food and Drug Administration (FDA), that would prohibit most flavored e-cigarettes, including mint and menthol-flavored products, from being on the market.
New initiative launches on heels of 33 states investigating more than 450 cases of lung illnesses associated with vaping, many of which involve teens and young adults
More than 700 cancer patients, survivors and their loved ones from all 50 states and nearly every congressional district will be on Capitol Hill this week to ask members of Congress to make the fight against cancer a national priority
WASHINGTON, D.C. – The large, graphic cigarette health warnings proposed today by the U.S. Food and Drug Administration are a critical and long-overdue step forward in the nation’s battle against tobacco use – the number one cause of preventable death.
Today the Senate Finance Committee is marking up the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, which includes a provision to cap Medicare beneficiaries’ out-of-pocket prescription drug costs in Medicare Part D, among several other proposed changes intended to bring down patient costs.
Washington, D.C. – Today the House Oversight and Reform Subcommittee on Economic and Consumer Policy is holding the first of two days of hearings examining JUUL’s role in the ongoing youth tobacco epidemic.